By combining fatty acid analyses, mass spectrometry-based O-GlcNAc site-mapping, expression of FASN O-GlcNAcylation mutants, Western blotting, and cellular assays, this study highlights the role of O-GlcNAcylation on FASN in HCC cells. The gene discussed is FASN; the disease is hepatocellular carcinoma.